EP Patent

EP3804686B1 — Intravenous infusion dosage form for pemetrexed

Assigned to Sun Pharmaceutical Industries Ltd · Expires 2023-08-30 · 3y expired

What this patent protects

Patent listed against pemetrexed-disodium.

Drugs covered by this patent

pemetrexed-disodium (PEMETREXED DISODIUM)

Patent Metadata

Patent number: EP3804686B1
Jurisdiction: EP
Classification: —
Expires: 2023-08-30
Drug substance claim: No
Drug product claim: No
Assignee: Sun Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.